N.J. Brereton

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin

Vivek Y. Reddy, R. Akehurst, Shannon Armstrong et al. · EP Europace · 2016 · 51 citations · Full text

Medicine, Cardiology, Pharmacoeconomics +17

The Cost Effectiveness of Licensed Oromucosal Midazolam (Buccolam®) for the Treatment of Children Experiencing Acute Epileptic Seizures: An Approach When Trial Evidence is Limited

Dawn Lee, Daniel Gladwell, A. Batty et al. · Pediatric Drugs · 2013 · 35 citations

Pharmacy, Pediatrics, Pharmacotherapy +14

The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands

R. Akehurst, N.J. Brereton, Rinat Ariely et al. · Journal of Medical Economics · 2011 · 32 citations

Pharmacy, Pharmacoeconomics, Bone Metabolism +16

Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland

Dawn Lee, Patrick Thornton, Alexander Hirst et al. · Applied Health Economics and Health Policy · 2013 · 27 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +10

The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial

N.J. Brereton, Bryan J. Winn, R. Akehurst · Journal of Medical Economics · 2012 · 23 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17